Ji Young Lee

Ji Young Lee

Auto-generated profile, based on publicly available information

Ji Young Lee

Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2017 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
WRWee-Jin Rah
Wee-Jin Rah
YLYoung-Ho Lee
Young-Ho Lee
JMJin-Hwa Moon
Jin-Hwa Moon
HJHyun-Ju Jun
Hyun-Ju Jun
HKHye-Ryeong Kang
Hye-Ryeong Kang
SKSeung hyun Kim
Seung hyun Kim
We performed a randomized, double-blind, cross-over study to assess the neuroregenerative potential of intravenous granulocyte colony-stimulating factor (G-CSF) followed by infusion of mobilized peripheral blood mononuclear cells (mPBMCs) in children with cerebral palsy (CP). Children with non-severe CP were enrolled in this study. G-CSF was administered for 5 days, then mPBMCs were collected by apheresis and cryopreserved. One month later (M1), recipients were randomized to receive either mPBMCs or a placebo infusion, and these treatment groups were switched at 7 months (M7) and observed for another 6 months (M13). We assessed the efficacy of treatment by evaluating neurodevelopmental tests, as well as by brain magnetic resonance imaging-diffusion tensor imaging (MRI-DTI) and 18F-fluorodeoxyglucose (FDG) brain positron emission tomography-computed tomography (PET-CT) scanning to evaluate the anatomical and functional changes in the brain. Fifty-seven patients aged 4.3 ± 1.9 (range 2–10) years and weighing 16.6 ± 4.9 (range 11.6–56.0) kg were enrolled in this study. The administration of G-CSF as well as the collection and reinfusion of mPBMCs were safe and tolerable. The yield of mPBMCs was comparable to that reported in studies of pediatric donors without CP and patients with nonhematologic diseases. 42.6% of the patients responded to the treatment with higher neurodevelopmental scores than would normally be expected. In addition, larger changes in neurodevelopment test scores were observed in the 1 month after G-CSF administration (M0–M1) than during the 6 months after reinfusion with mPBMCs or placebo (M1–M7 or M7–M13). Patients who received G-CSF followed by mPBMC infusion at 7 months (T7 group) demonstrated significantly more neurodevelopmental improvement than patients who received G-CSF followed by mPBMC infusion at 1 month (T1 group). In contrast to the results of neurodevelopment tests, the results of MRI-DTI at the end of this study showed greater improvement in the T1 group. Although we observed metabolic changes to the cerebellum, thalamus and cerebral cortex in the 18F-FDG brain PET-CT scans, there were no significant differences in such changes between the mPBMC and placebo group or between the T1 and T7 group. Neurodevelopmental improvement was seen in response to intravenous G-CSF followed by mPBMC reinfusion, particularly to the G-CSF alone even without mPBMC reinfusion. Further studies using a larger number of mPBMCs for the infusion which could be collected by repeated cycles of apheresis or using repeated cycles of G-CSF alone, are needed to clarify the effect of mPBMC reinfusion or G-CSF alone (Trial registration: ClinicalTrials.gov, NCT02983708. Registered 5 December, 2016, retrospectively registered).

1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
JLJi Young Lee
Ji Young Lee
SOSe Won Oh
Se Won Oh
MCMi Sun Chung
Mi Sun Chung
JPJi Eun Park
Ji Eun Park
YMYeonsil Moon
Yeonsil Moon
WMWon-Jin Moon
Won-Jin Moon
Lee JY, et al. Korean J Radiol. 2020 Jul;21:e171. https://doi.org/10.3348/kjr.2020.0518

1 July 2017 in Oral Oncology
Verified
Journal Article
Closed access
YJYong Bae Ji
Yong Bae Ji
CSChang Myeon Song
Chang Myeon Song
HBHyang Sook Bang
Hyang Sook Bang
HPHae Jin Park
Hae Jin Park
JLJi Young Lee
Ji Young Lee
KTKyung Tae
Kyung Tae

1 January 2021 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
YYYounghee Yim
Younghee Yim
JLJi Young Lee
Ji Young Lee
SOSe Won Oh
Se Won Oh
MCMi Sun Chung
Mi Sun Chung
JPJi Eun Park
Ji Eun Park
WMWon-Jin Moon
Won-Jin Moon
Yim Y, et al. Yonsei Med J. 2021 Mar;62(3):255-261. https://doi.org/10.3349/ymj.2021.62.3.255

1 January 2021 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
JLJungbin Lee
Jungbin Lee
JLJi Young Lee
Ji Young Lee
SOSe Won Oh
Se Won Oh
MCMi Sun Chung
Mi Sun Chung
JPJi Eun Park
Ji Eun Park
WMWon-Jin Moon
Won-Jin Moon
Lee J, et al. J Clin Neurol. 2021 Apr;17(2):307-316. https://doi.org/10.3988/jcn.2021.17.2.307

22 October 2019 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
JLJi Young Lee
Ji Young Lee
MHMiran Han
Miran Han
KKKap Seon Kim
Kap Seon Kim
SSSu-Jin Shin
Su-Jin Shin
JCJin Wook Choi
Jin Wook Choi
EHEun Ju Ha
Eun Ju Ha